Abstract
Glaucoma has been recognized for several hundred years. Initially, it was defined as an eye disease of characteristic structural change of optic nerves and specific visual field change caused by increased intraocular pressure (IOP). However, when we comprehended the development and progress of glaucoma only limiting to the perspective of the eye itself, we could hardly interpret some problems we encountered clinically. For example, some glaucoma patients’ IOP is in the normal range (normal-tension glaucoma); some people have long-term IOP higher than the normal range, and there is no pathological change of their optic nerves though; some glaucoma patients have IOP controlled in normal range by drugs or surgeries, while impairment of their optic nerves and vision is still gradually worsening; and some patients with disease of the nervous system have glaucoma at the same time. Are those phenomena occasional, or are there some correlations not yet discovered? In order to answer the above questions, the ophthalmologists have expanded their vision, comprehended beyond eyeball level, and proposed an innovative theory of “trans-lamina cribrosa pressure gradient,” that a concept as “glaucoma being a disease of central visual pathway” by considering both ocular pathological changes and body fluid circulation in combination, which shall open a wide field for glaucoma study.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Glaucoma has been recognized for several hundred years. Initially, it was defined as an eye disease of characteristic structural change of optic nerves and specific visual field change caused by increased intraocular pressure (IOP). However, when we comprehended the development and progress of glaucoma only limiting to the perspective of the eye itself, we could hardly interpret some problems we encountered clinically. For example, some glaucoma patients’ IOP is in the normal range (normal-tension glaucoma); some people have long-term IOP higher than the normal range, and there is no pathological change of their optic nerves though; some glaucoma patients have IOP controlled in normal range by drugs or surgeries, while impairment of their optic nerves and vision is still gradually worsening; and some patients with disease of the nervous system have glaucoma at the same time. Are those phenomena occasional, or are there some correlations not yet discovered? In order to answer above questions, the ophthalmologist have started to explore the structures beyond the eyeball per se, and proposed an innovative theory of “trans-lamina cribrosa pressure gradient”, a concept that defines glaucoma as “a disease of central visual pathway” by considering both ocular pathological changes and body fluid circulation, which shall open a new chapter in glaucoma study.
In this article, we reviewed some milestone studies of “trans-lamina cribrosa pressure gradient in glaucoma” to retrospect the road map for the pathogenesis of glaucomatous optic neuropathy (Fig. 1.1).
In 1976, Volkov VV first discussed about the effect of low CSF pressure on glaucoma [1]. In 1979, Yablonski ME, Ritch R, and Pokorny KS found chronic lowering of intracranial pressure led to glaucoma damage of the optic nerve and that simultaneous lowering of IOP prevented damage [2]. At this time, the hypothesis that low cerebrospinal fluid pressure (CSFp) might be involved in glaucoma was proposed.
Thirty years later, two clinical studies, a prospective study from Tongren Hospital [3] and a retrospective study from Duke [4], both found that cerebrospinal fluid pressure was low in NTG patients. These are pioneer clinical studies focusing on the role of CSFp in the pathogenesis of glaucoma. The same study groups did some further studies based on the concept of trans-lamina cribrosa pressure difference (TLPD). The results suggested that the TLPD as compared to the IOP was significantly better correlated with cup to disc ratio, rim width, and visual field loss [5]. This may provide some indirect evidence that the CSFp might play some role in the pathogenesis of glaucomatous optic neuropathy.
Followed by this lead, the same study groups found that body mass index (BMI) had a positive linear relationship with CSFp, whereas IOP was unaffected by BMI and CSFp [6, 7]. This finding indicated that the higher BMI may be a protective factor for glaucoma.
In 2011, Mader et al. [8] first reported that after long-duration space flight, optic disc edema, globe flattening, choroidal folds, and hyperopic shifts were observed in astronauts. This finding proved that zero-gravity environment may cause CSFp elevation and a reversal TLPD. As the optic change of the astronauts was opposite of the glaucomatous neuropathy, we may speculate that the TLPD-related conditions existed and breaking the balance of difference between IOP and CSFp may cause either side of the optic neuropathy.
In practice, lumbar puncture is often used to measure the CSFp. However, the CSFp at the lumbar area cannot represent the CSFp around the optic nerve. In addition, there’s no indication for POAG patients to perform the lumber puncture. Therefore, our team proposed a noninvasive method to measure the orbital CSFp with MRI [9]. According to the image, we found that CSFp around the optic nerve was decreased in NTG patients, which further approved our former findings (Fig. 1.2).
At the same time, Dr. Killer et al. [10] described a compartment syndrome of subarachnoid space of the nerve in glaucoma first. In the study, they found that the circulation of CSF in the subarachnoid space of the nerve and the brain cannot communicate with the CSF around the ventricle, so the CSF there just keep static around the optic nerve. This is the new hypothesis that CSF circulation may be disrupted and a chemical toxic effect may damage the optic nerve.
Recently, our team analyzed the correlation between ICP and IOP in normal dog models and found three different stages of the ICP-IOP relationship [11]. There is an ICP-IOP dependent zone where ICP and IOP change in parallel, so the TLPD is unchanged. Right below the breakpoint, which is the second stage, there is also an ICP-IOP independent zone, where IOP changes no longer parallel ICP changes and lead to an increasing TLPD. We proposed that the imbalanced relationship between ICP and IOP may play a role in the glaucomatous optic neuropathy in patients with lower ICP.
Beijing iCOP study group made the monkey model by lowering of CSFp by placing the lumbar peritoneal shunt [12]. After 1 year, we found five out of eight eyes show optic neuropathy changes similar to glaucoma (Fig. 1.3). Then, we did the comparative study between high IOP and low ICP monkey model and found that nearly all the glaucomatous optic neuropathy-related parameters showed similar changes; however, the deformation and thinning of lamina cribrosa only existed in the high IOP model. Moreover, after another year of observation, there were no any further changes or damages in the optic nerve and nerve fiber layers in monkeys. Why does optic damage ceased?
The same study group used the infinite analysis method to answer the question. In the infinite model, at the same level of TLPD, elevated IOP caused more severe deformation than that in reduced CSFp condition. Moreover, lower CSFp group exhibited less cup to disc ratio change than that in the higher IOP group.
Zhang et al. [13] used the lower CSFp rats to observe the optic changes without the deformation of lamina cribrosa. They found that both short-term lowering CSFp and acute rising in IOP were all associated with a disturbance of both the orthograde and retrograde axonal transport (Fig. 1.4). Furthermore, the results showed an accumulation of dynein IC (intermediate chain) at the optic nerve head and retina when the TLPD dramatically increased. Meanwhile, the kinesin HC (heavy chain) immunoreactivity in the optic nerve fiber axons reduced. From this study, we note that the low CSFp or mild IOP elevation can cause the failure of axonal transport, while high IOP cannot just cause the failure of axonal transport but also the direct stress on laminar RGC loss. Therefore, a new hypothesis was proposed that lower CSFp may only affect axonal transport but have no effect on lamina cribrosa structure, although TLPD increased with higher IOP or lower CSFp.
So far, the pressure difference we study now is static. As we know, IOP and ICP change with the heartbeats and respiratory rhythm. Professor Cynthia Roberts et al. (unpublished) proposed another hypothesis that ocular pulse amplitude (OPA) that interacts with cerebral pulse amplitude (CPA) would cause nerve damage. Of these, the sclera stiffness plays an important risk factor. So we get the new ideas about the TLPD; we should not only think it in static but also in dynamics. What’s more, the optic nerve damage has not only happened in the site of the laminar cribrosa but all along the optic nerve, where pressure gradients exist. So the concept of “trans-lamina cribrosa pressure difference” may be changed into “optic nerve pressure gradient (ONPG)” to be more precise (Fig. 1.5).
In review of the literatures, either in the prospective study or retrospective study, we found that not every normal-tension glaucoma patient had lower CSFp [3, 14,15,16,17]. Besides the different ICP measurements, some other possible factors should be considered, such as the different definitions of NTG and racial differences as BMI is related to the CSFp which was mentioned before. Since all the related studies have small sample sizes, we suggested that a further international cooperative study among different ethnic groups based on standard protocol is in need.
In conclusion, POAG is an entity of diseases that is caused by various reasons but with characterized optic neuropathy. The future directions include noninvasive measurement of CSFp and IOP dynamics and the change of optic blood flow; therefore, we may have the new classification or the formula to calculate the risk factors and the technique to rebalance the IOP and ICP.
References
Volkov VV. Essential element of the glaucomatous process neglected in clinical practice. Oftalmol Zh. 1976;31:500–4.
Yablonski MRR, Pokorny KS. Effect of decreased intracranial pressure on optic disc. Invest Ophthalmol Vis Sci. 1979;18(Suppl):165.
Ren R, Jonas JB, Tian G, Zhen Y, Ma K, Li S, et al. Cerebrospinal fluid pressure in glaucoma: a prospective study. Ophthalmology. 2010;117(2):259–66.
Berdahl JP, Fautsch MP, Stinnett SS, Allingham RR. Intracranial pressure in primary open angle glaucoma, normal tension glaucoma, and ocular hypertension: a case-control study. Invest Ophthalmol Vis Sci. 2008;49(12):5412–8.
Ren R, Wang N, Zhang X, Cui T, Jonas JB. Trans-lamina cribrosa pressure difference correlated with neuroretinal rim area in glaucoma. Graefes Arch Clin Exp Ophthalmol. 2011;249(7):1057–63.
Ren R, Wang N, Zhang X, Tian G, Jonas JB. Cerebrospinal fluid pressure correlated with body mass index. Graefes Arch Clin Exp Ophthalmol. 2012;250(3):445–6.
Berdahl JP, Fleischman D, Zaydlarova J, Stinnett S, Allingham RR, Fautsch MP. Body mass index has a linear relationship with cerebrospinal fluid pressure. Investig Ophthalmol Vis Sci. 2012;53:1422e7.
Mader TH, Gibson CR, Pass AF, Kramer LA, Lee AG, Fogarty J, et al. Optic disc edema, globe flattening, choroidal folds, and hyperopic shifts observed in astronauts after long-duration space flight. Ophthalmology. 2011;118(10):2058–69.
Wang N, Xie X, Yang D, Xian J, Li Y, Ren R, et al. Orbital cerebrospinal fluid space in glaucoma: the Beijing intracranial and intraocular pressure (iCOP) study. Ophthalmology. 2012;119(10):2065–73. e1
Killer HE. Compartment syndromes of the optic nerve and open-angle glaucoma. J Glaucoma. 2013;22(Suppl 5):S19–20.
Hou R, Zhang Z, Yang D, Wang H, Chen W, Li Z, et al. Pressure balance and imbalance in the optic nerve chamber: The Beijing Intracranial and Intraocular Pressure (iCOP) Study. Sci China Life Sci. 2016;59(5):495–503.
Yang D, Fu J, Hou R, Liu K, Jonas JB, Wang H, et al. Optic neuropathy induced by experimentally reduced cerebrospinal fluid pressure in monkeys. Invest Ophthalmol Vis Sci. 2014;55(5):3067–73.
Zhang Z, Wu S, Jonas JB, Zhang J, Liu K, Lu Q, et al. Dynein, kinesin and morphological changes in optic nerve axons in a rat model with cerebrospinal fluid pressure reduction: the Beijing Intracranial and Intraocular Pressure (iCOP) study. Acta Ophthalmol. 2016;94(3):266–75.
Berdahl JPAR, Johnson DH. Cerebrospinal fluid pressure is decreased in primary open-angle glaucoma. Ophthalmology. 2008;115(5):763–8.
Linden C, Qvarlander S, Johannesson G, Johansson E, Ostlund F, Malm J, et al. Normal-Tension Glaucoma Has Normal Intracranial Pressure: A Prospective Study of Intracranial Pressure and Intraocular Pressure in Different Body Positions. Ophthalmology. 2018;125(3):361–8.
Pircher A, Remonda L, Weinreb RN, Killer HE. Translaminar pressure in Caucasian normal tension glaucoma patients. Acta Ophthalmol. 2017;95(7):e524–e31.
Siaudvytyte L, Januleviciene I, Ragauskas A, Bartusis L, Meiliuniene I, Siesky B, et al. The difference in translaminar pressure gradient and neuroretinal rim area in glaucoma and healthy subjects. J Ophthalmol. 2014;2014:937360.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Wang, N. (2019). Road Map for the Pathogenesis of Glaucomatous Optic Neuropathy. In: Wang, N. (eds) Intraocular and Intracranial Pressure Gradient in Glaucoma. Advances in Visual Science and Eye Diseases, vol 1. Springer, Singapore. https://doi.org/10.1007/978-981-13-2137-5_1
Download citation
DOI: https://doi.org/10.1007/978-981-13-2137-5_1
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-2136-8
Online ISBN: 978-981-13-2137-5
eBook Packages: MedicineMedicine (R0)